1054 Paroxetin, a Selective 5-Hydroxytryptamine RE-Uptake Inhibitor, Increases Postprandial Gastric Volumes and Decreases Symptoms in Patients with Postprandial Distress Syndrome (PDS) Functional Dyspepsia (FD)